Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313190999> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2313190999 endingPage "698" @default.
- W2313190999 startingPage "695" @default.
- W2313190999 abstract "Fear of blushing (FB) is a form of social anxiety disorder (SAD) characterized by an intense and obsessive threat of blushing in front of other people. No data are available on the specific efficacy of antidepressants on FB. This open-label pilot study investigated whether the selective serotonin reuptake inhibitor escitalopram specifically improves symptoms of FB in SAD patients. Thirty-nine patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for SAD and presenting a significant FB according to the Salpêtrière Erythrophobia Questionnaire (SEQ) were administered open-label escitalopram (10–30 mg/d) for 12 weeks. A systematic assessment, at baseline and at week 12, included the SEQ, the Liebowitz Social Anxiety Scale, and the Hospital Anxiety and Depression scale. From the 39 patients included, 31 attended the week 4 visit, and 28 the week 12 visit. Significant reductions of FB were observed after 4 weeks of treatment and were more pronounced at the end of the 12-week treatment since patients experienced a 60% decrease in their FB symptoms (P < 0.001). Nineteen subjects (67.8%) reported a 50% decrease or more of their SEQ score, and 14 (50%) met criteria for remission of FB (SEQ score <7). The effect sizes of changes on SEQ, Liebowitz Social Anxiety Scale, and Hospital Anxiety and Depression scale scores were high, with η2 ranging between 0.53 and 0.86. Results of this open-label study suggest that escitalopram can be a useful treatment for FB associated with SAD, even if large controlled trials are now needed to further evaluate this result." @default.
- W2313190999 created "2016-06-24" @default.
- W2313190999 creator A5016527233 @default.
- W2313190999 creator A5065520313 @default.
- W2313190999 date "2013-10-01" @default.
- W2313190999 modified "2023-09-25" @default.
- W2313190999 title "Open-Label Treatment With Escitalopram in Patients With Social Anxiety Disorder and Fear of Blushing" @default.
- W2313190999 cites W1978826139 @default.
- W2313190999 cites W1982134238 @default.
- W2313190999 cites W1985227798 @default.
- W2313190999 cites W1990802473 @default.
- W2313190999 cites W1996788768 @default.
- W2313190999 cites W2022727555 @default.
- W2313190999 cites W2042440405 @default.
- W2313190999 cites W2048801162 @default.
- W2313190999 cites W2075736632 @default.
- W2313190999 cites W2108592835 @default.
- W2313190999 cites W2108843007 @default.
- W2313190999 cites W2128277170 @default.
- W2313190999 cites W2166281097 @default.
- W2313190999 cites W2170521677 @default.
- W2313190999 cites W2423939061 @default.
- W2313190999 cites W297380673 @default.
- W2313190999 doi "https://doi.org/10.1097/jcp.0b013e31829a878b" @default.
- W2313190999 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23948787" @default.
- W2313190999 hasPublicationYear "2013" @default.
- W2313190999 type Work @default.
- W2313190999 sameAs 2313190999 @default.
- W2313190999 citedByCount "6" @default.
- W2313190999 countsByYear W23131909992015 @default.
- W2313190999 countsByYear W23131909992016 @default.
- W2313190999 countsByYear W23131909992018 @default.
- W2313190999 countsByYear W23131909992020 @default.
- W2313190999 crossrefType "journal-article" @default.
- W2313190999 hasAuthorship W2313190999A5016527233 @default.
- W2313190999 hasAuthorship W2313190999A5065520313 @default.
- W2313190999 hasConcept C118552586 @default.
- W2313190999 hasConcept C126322002 @default.
- W2313190999 hasConcept C139719470 @default.
- W2313190999 hasConcept C15744967 @default.
- W2313190999 hasConcept C162324750 @default.
- W2313190999 hasConcept C2776317618 @default.
- W2313190999 hasConcept C2776867660 @default.
- W2313190999 hasConcept C2777545354 @default.
- W2313190999 hasConcept C2779177272 @default.
- W2313190999 hasConcept C2779583969 @default.
- W2313190999 hasConcept C3019800554 @default.
- W2313190999 hasConcept C535046627 @default.
- W2313190999 hasConcept C558461103 @default.
- W2313190999 hasConcept C71924100 @default.
- W2313190999 hasConceptScore W2313190999C118552586 @default.
- W2313190999 hasConceptScore W2313190999C126322002 @default.
- W2313190999 hasConceptScore W2313190999C139719470 @default.
- W2313190999 hasConceptScore W2313190999C15744967 @default.
- W2313190999 hasConceptScore W2313190999C162324750 @default.
- W2313190999 hasConceptScore W2313190999C2776317618 @default.
- W2313190999 hasConceptScore W2313190999C2776867660 @default.
- W2313190999 hasConceptScore W2313190999C2777545354 @default.
- W2313190999 hasConceptScore W2313190999C2779177272 @default.
- W2313190999 hasConceptScore W2313190999C2779583969 @default.
- W2313190999 hasConceptScore W2313190999C3019800554 @default.
- W2313190999 hasConceptScore W2313190999C535046627 @default.
- W2313190999 hasConceptScore W2313190999C558461103 @default.
- W2313190999 hasConceptScore W2313190999C71924100 @default.
- W2313190999 hasIssue "5" @default.
- W2313190999 hasLocation W23131909991 @default.
- W2313190999 hasLocation W23131909992 @default.
- W2313190999 hasOpenAccess W2313190999 @default.
- W2313190999 hasPrimaryLocation W23131909991 @default.
- W2313190999 hasRelatedWork W1697346090 @default.
- W2313190999 hasRelatedWork W1789391872 @default.
- W2313190999 hasRelatedWork W2037922736 @default.
- W2313190999 hasRelatedWork W2057097477 @default.
- W2313190999 hasRelatedWork W2072921494 @default.
- W2313190999 hasRelatedWork W2091004398 @default.
- W2313190999 hasRelatedWork W2101092018 @default.
- W2313190999 hasRelatedWork W2103617903 @default.
- W2313190999 hasRelatedWork W2158886349 @default.
- W2313190999 hasRelatedWork W2313190999 @default.
- W2313190999 hasVolume "33" @default.
- W2313190999 isParatext "false" @default.
- W2313190999 isRetracted "false" @default.
- W2313190999 magId "2313190999" @default.
- W2313190999 workType "article" @default.